Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B cell malignancies

Faculty of Medicine, Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway

Faculty of Mathematics and Natural Sciences, Department of Biosciences, University of Oslo, Oslo, Norway

Search for more papers by this author

留言 (0)

沒有登入
gif